MedTrace Logo

Sleep to Prevent Evolving Affecting Disorders

NCT02988375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1385

Last updated 2024-01-12

Study results available
· View outcomes & findings →

Summary

The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. In addition, we will identify salient sociological/environmental variables, such as age, sex, education, socioeconomic status (SES), racial/ethnic minority-status, work schedule, child-care responsibilities (i.e., having children under the age of 3), stigma, that moderate the effects of this intervention.

Conditions

Interventions

BEHAVIORAL

dCBTI

BEHAVIORAL

Sleep Education

Sponsors & Collaborators

  • Robert Wood Johnson Foundation

    collaborator OTHER

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Christopher Drake, PhD · Henry Ford Medical Center - Columbus

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-08
Primary Completion
2018-04-26
Completion
2018-09-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02988375 on ClinicalTrials.gov